Response to Pharmacological Treatment in Major Depression Predicted by Electroencephalographic Alpha Power - a Pilot Naturalistic Study von Kandilarova, Sevdalina S, Terziyski, Kiril V, Draganova, Aneliya I, Stoyanov, Drozdstoy S, Akabaliev, Valentin H, Kostianev, Stefan S

Volltext

Dermatoglyphics – a Possible Biomarker in the Neurodevelopmental Model for the Origin of Mental Disorders von Ahmed-Popova, Ferihan M., Mantarkov, Mladen J., Sivkov, Stefan T., Akabaliev, Valentin H.

Volltext

Brain-Derived Neurotrophic Factor and Its Serum Levels in Schizophrenic Patients von Koeva, Yvetta A., Sivkov, Stefan T., Akabaliev, Valentin H., Ivanova, Roumiana Y., Deneva, Tania I., Grozlekova, Lilia S., Georgieva, Vessela

Volltext

Discriminating Value of Total Minor Physical Anomaly Score on the Waldrop Physical Anomaly Scale Between Schizophrenia Patients and Normal Control Subjects von Sivkov, Stefan T, Akabaliev, Valentin H

Volltext

Biomarker profile of minor physical anomalies in schizophrenia patients von Akabaliev, Valentin H, Sivkov, Stefan T, Mantarkov, Mladen J, Ahmed-Popova, Ferihan M

Volltext

Sexual dimorphism in minor physical anomalies in schizophrenic patients and normal controls von Akabaliev, Valentin H, Sivkov, Stefan T

Volltext

Minor physical anomalies in mentally healthy subjects: Internal consistency of the Waldrop Physical Anomaly Scale von Sivkov, Stefan T., Akabaliev, Valentin H.

Volltext

A placebo-controlled study of three agomelatine dose regimens (10 mg, 25 mg, 25–50 mg) in patients with major depressive disorder von Kennedy, Sidney H, Avedisova, Alla, Giménez-Montesinos, Natalia, Belaïdi, Carole, Christian de, Bodinat

Volltext